Cell-matrix interaction through specific adhesion molecules is a critical step during organ development.
In addition, down-regulation of cell adhesion receptors may promote tumor invasion and metastasis. We show here that the Wilms' tumor suppressor Wt1, which is necessary for normal development of the epicardium, coronary vessels, genitourinary system, and other tissues, activates transcription of the α α α α4integrin gene. ).
These findings demonstrate that Wt1 can support cell adhesion through enhanced expression of α α α α4integrin. This transcriptional activation of the α α α α4integrin gene by Wt1(-KTS) might contribute to normal formation of the epicardium and other tissues in the developing embryo.
The Wilms' tumor gene, Wt1, encodes a zinc finger protein, which exerts a dual role as a tumor suppressor and a critical regulator of embryonic development (1-3).
Inactivating mutations in the Wt1 gene on human chromosome 11p13 occur in approx. 10% of sporadic Wilms' tumors (4), a common childhood malignancy that arises from a failure of pluripotent cells in the developing kidney to differentiate into glomeruli and tubules (5,6). Targeted gene inactivation revealed a requirement of Wt1 for cardiac development and the formation of the genitourinary system and other tissues. Wt1-deficient mouse embryos (Wt1 -/-) are lethal with a failure of normal development of the heart, kidneys, gonads (3), spleen (7), adrenal glands (8) and mesothelial structures (3, 8) . We have recently found that Wt1 is also necessary for the formation of neural tissues, i.e. the retina (9) and olfactory epithelium (10) .
How the Wt1 suppressor fulfils its diverse roles on a molecular basis is still unclear. More than two dozens Wt1 proteins are generated by alternative mRNA splicing (11) , the use of variable translation start sites (12, 13) , and RNA editing (14) . Among the Wt1 isoforms alternatively spliced exon 5 encodes 17 amino acids, and the use of two alternative splice donor sites at the end of exon 9 results in the insertion/omission of a tripeptide (lysinethreonine-serine, KTS) in the zinc finger domain of the Wt1 protein (11) . The Wt1(+KTS) forms with the tripeptide insertion have a presumed role in mRNA processing (15) (16) (17) (18) , whereas Wt1(-KTS) proteins, which lack the KTS peptide, function as transcription factors (reviewed in 19, 20) . A variety of Wt1 candidate target genes were identified, mainly by assessing the effect of transiently transfected Wt1 on their promoter activities.
Putative downstream mediators of Wt1 include genes encoding growth factors and their receptors (21) (22) (23) , transcription factor genes (24) (25) (26) , genes for extracellular proteins (27, 28) , cell cycle regulators (29) , and others (reviewed in 19). However, only very few of the proposed targets could be verified as bona fide downstream effectors of Wt1.
Another group of genes that are considered as potential Wt1 targets encode for cell adhesion molecules.
Cell-cell contact formation and cell-matrix interaction through specific membrane proteins is a critical step during organ development (reviewed in 30). Moreover, down-regulation of adhesion receptors may enable malignant cells to migrate from a primary neoplasm into the adjacent tissue and the circulatory system, thereby promoting tumor invasion and metastasis (reviewed in 31). Among the cell adhesion receptors, integrins comprise a family of αβ heterodimeric glycoproteins, which have been implicated in development and disease (reviewed in 32).
Integrins that contain the α4 subunit associate with β1 or β7, and bind to fibronectin, a major constituent of the extracellular matrix (33, 34) . Vascular cell adhesion molecule-1 (VCAM-1) is another binding partner of α4β1integrin (35, 36) . The requirement for α4integrin during murine embryogenesis is indicated by the early lethality of embryos with homozygous disruption of the α4integrin gene (37) . Remarkably, defects seen in the α4integrin-null mutants are reminiscent of the phenotype of mice with Wt1 deficiency, i.e. α4integrin-deficient embryos -like Wt1 knockouts (3,8,38) -have an abnormal formation of the epicardium and coronary vessel system (37) . Furthermore, α4integrin and Wt1, by regulating the proliferation of progenitor cells, have both been implicated in normal hematopoiesis of murine embryos (39) (40) (41) . These findings suggest that Wt1 and α4integrin may act synergistically during critical steps of development. Our present results support a coordinated action of both molecules in epicardial formation by demonstrating that Wt1 activates transcription of the α4integrin gene, which promotes cell adhesion. Sequence information of the primers that were used for PCR amplification is given in Table 1 . The PCR products were ligated into the SacI and HindIII sites of the pGL2basic reporter plasmid (Promega). A PCR-based strategy was applied to introduce site-directed mutations into two identified Wt1 binding elements (oligo A and oligo B) of the α4integrin promoter (see below). The correct identity of all constructs was verified by automated dideoxy sequencing. Reverse transcription (RT) real-time PCR -Total RNA was isolated from cultured cells and embryonic mouse tissues (E12.5) using the Trizol reagent (Invitrogen). The RNA pellets were dissolved in diethyl pyrocarbonate-treated H 2 O.
EXPERIMENTAL PROCEDURES

Animals
First-strand cDNA synthesis was performed with 2 µg of total RNA using oligo(dT) primers and superscript II reverse transcriptase (Invitrogen). One percent of the volume of the reaction product was taken for quantitative real-time PCR amplification with Sybr  Green PCR Master Mix (Roche, Applied Biosystems) according to the following protocol: DNA denaturation at 94°C, primer annealing (10 sec) and extension of double-stranded DNA at 60°C (60 sec), measurement of Sybr  Green fluorescence at 77°C (30 sec) for 45 cycles (GeneAmp5700, Applied Biosciences, Foster City, CA). The primers that were used for realtime RT-PCR are listed in Table 1 . Transcript levels were determined on the basis of differences in the C t values as described previously (48) . Electrophoretic mobility shift assaysElectrophoretic mobility shift assays (EMSAs) were performed with purified recombinant GSTWt1 protein as described in detail elsewhere (45) . The DNA binding reactions were carried out on ice for 15 min in 20 µl of a 1x reaction buffer (10 mM Tris-HCl, pH 7.5, 50 mM KCl, 50 mM NaCl, 1 mM MgCl 2 , 1 mM EDTA, 5 mM DTT, 5% glycerol, 0.05 mg/ml herring sperm DNA). Double-stranded oligonucleotides, which are contained within the Wt1-inducible α4integrin promoter fragment, were selected by their sequence homology with known Wt1 consensus sites: oligoA (-263 to -238 bp): 5'-TGGCAACTGAGTGGGTGCGTGAAAAG-3', oligoB (-70 to -47 bp): 5'-AGAGGAAGTGTGGGGAGGAAGGAA-3'). Single nucleotide mutations were designed to test for the specificity of Wt1 binding: mutant oligoA:
5'-TGTCAACTGAGTTGGTTCTTGAAAAG-3' and mutant oligoB:
Competition experiments were performed with excess amounts of a non-radioactive 21-bp oligoncleotide containing the previously identified Wt1(-KTS) binding site in the vitamin D receptor gene promoter (5'-TGAACTTAGTGGGCGTGGTTG-3') (42). The binding reactions were run for 3h on nondenaturing 8% polyacrylamide gels at 4ºC and autoradiographed. Chromatin immunoprecipitation (ChIP) assayChromatin immunoprecipitation assay (ChIP) was done with K562 cells, which express the α4integrin gene (49), as described (50) . Antibodies (2 µg each) against acetylated histone 3 (rabbit polyclonal antibody, #06-599, Upstate, Lake Placid, NY), and Wt1 (rabbit polyclonal antibody, C-19, Santa Cruz Biotechnology) were used. Normal rabbit serum served as negative control, a 1:10 dilution of the 'input' sample as positive control. Following immunoprecipitation, the purified DNA was eluted in 50 µl UltraPure DNAse, RNAse free ddH 2 O (Gibco/Invitrogen, #10977-015). For amplification of purified DNA fragments by PCR, 0.5 µl of the input DNA (diluted in a total volume of 5 µl ddH 2 O), 5 µl of the "normal serum" sample, and 5 µl of immunoprecipitated DNA were mixed each with primers, PCR buffer, dNTPs, and AmpliTaq DNA Polymerase (Applied Biosystems, Roche). The following primer pairs were used: human α4integrin promoter (NCBI accession no. L26059): 5'-CGTGAGCTCTAAAAGCAGGTGTGTCCCG T-3' (forward primer), 5'-CGCAAGCTTTGGCTATTCTCTTCAAGACC C-3' (reverse primer), human α4integrin 3'-region (NCBI accession no. BC080190): 5'-TAAGAGAGCTGTGGCCGAAT-3' (forward primer), 5'-TCTGGGTTCAGGAGGTTTTG-3' (reverse primer). All samples were processed in the same PCR reaction (32 cycles) at an annealing temperature of 55°C. The PCR products were electrophoresed on a 1.2% agarose gel yielding DNA fragments of 283 bp (α4integrin promoter) and 235 bp (α4integrin 3'-region), respectively. SDS-PAGE -Membrane fractions were prepared from subconfluent cultures of HEK293 cells as described (51) and separated on a 10% polyacrylaminde gel. The proteins (20 µg per lane) were transferred onto polyvinylidene difluoride membranes (Amersham Pharmacia Biotech, Freiburg, Germany) with the use of a semidry blotting apparatus (BioRad, München, Germany). After blocking at room temperature for 60min in PBS, 5% non-fat milk (Roth, Karlsruhe, Germany), 0.05% Tween-20 (Serva, Heidelberg, Germany), incubation with one the following primary antibodies was performed in PBS, 2.5% non-fat milk, 0.05% Tween-20: polyclonal anti-α4integrin antibody from goat (C-20, cat.# sc-6589, Santa Cruz Biotechnology, 1:1.000 dilution), polyclonal anti-Wt1 antibody from rabbit (C-19, cat.# sc-846, Santa Cruz Biotechnology, 1:1.000 dilution), mouse monoclonal antibody against β-actin (cat.# MAB1501R, Chemicon, 1:1.000 dilution). Incubation with peroxidase-coupled secondary antibodies and visualization with the enhanced chemiluminescence system (Amersham) was performed as reported earlier (38, 42, 45) . Histology and immunohistochemistry -Morphological studies were performed as described in detail elsewhere (9,38,43). Staged embryos were fixed overnight at 4°C in paraformaldehyde (3% in PBS) and frozen in tissue-Tek O.C.T. compound (Sakura Finetek, Zoeterwoude, Netherlands). Ten µm cryostat sections were permeabilized with 0.1% Triton X-100 in PBS and blocked for 5 min at room temperature in serum-free DakoCytomation protein block (cat.# X0909, Dako, Hamburg, Germany).
An indirect immunofluorescent double-labeling technique was used to mark the Wt1 and α4integrin expressing cells with the following primary antibodies (1:50 dilution in ready-to-use antibody diluent, cat.# 00-3218, Zymed, Berlin, Germany): rabbit polyclonal anti-Wt1 antibody (C-19, cat.# sc-846, Santa Cruz Biotechnology), goat polyclonal antiα4integrin antibody (C-20, cat.# sc-6589, Santa Cruz Biotechnology). The reaction products were visualized by incubation (1.5h at room temperature) with Cy3-and Cy2-conjugates as described previously (9,38,43). The nuclei were counterstained with 4'-6-Diamidino-2-phenylindole (Dapi). Alternatively, three µm paraffin sections from wild-type embryos (E11.5) and their Wt1-deficient littermates were stained with an immunoperoxidase technique (38) . For this purpose, the slides were incubated with goat polyclonal anti-α4integrin antibody (1:50 dilutions in PBS, 0.1% Triton X-100, 3% BSA, C-20, cat.# sc-6589, Santa Cruz Biotechnology) or with goat polyclonal antivimentin antibody (1:50 dilutions in PBS, 0.1% Triton X-100, 3% BSA, cat.# sc-7557, Santa Cruz Biotechnology). The antigen detection was performed with a biotinylated anti-goat antibody (Vector Laboratories) followed by incubation with peroxidase-coupled Streptavidin (Sigma). The reaction was visualized with DAB substrate (Vector Laboratories, catalog no. SK-4100). Statistics -ANOVA with Bonferroni-test as post-hoc calculation and students' t-test were performed as indicated to reveal statistical significances. A P-value of less than 0.05 was considered statistically significant.
RESULTS
To explore whether Wt1 can activate the α4integrin gene, we took advantage of our previously established human embryonic kidney (HEK) 293 cells with stable Wt1 expression (42, 43) . Gene expression was measured by realtime RT-PCR in HEK293 cells with stable integration either of a Wt1(-KTS) expression plasmid or empty pCB6 + vector. Alpha4integrin mRNA, which was normalized against GAPDH transcripts, was increased more than 3-fold in Wt1(-KTS)-expressing compared to pCB6 + -transfected cells (Fig. 1A) . The increase of α4integrin in the Wt1(-KTS)-expressing HEK293 cells was confirmed at the protein level using a polyclonal antibody from goat for immunoblotting (Fig. 1B) . A lesser, though significant increase of ß1integrin transcripts was also seen in HEK293 cells with forced expression of Wt1(-KTS) (Fig. 1A) . In contrast, VCAM-1 mRNA levels were not significantly different between pCB6 + -and Wt1(-KTS)-transfected cells (Fig. 1A) . These findings demonstrate that forced expression of the Wt1(-KTS) protein stimulates α4integrin expression in kidney-derived HEK293 cells.
To validate the relationship between Wt1 and α4integrin and to analyze the underlying regulatory mechanism(s), we investigated whether Wt1 can activate the promoter of the α4integrin gene directly. For this purpose, a luciferase reporter construct containing the nucleotides between -1864 and +1 bp relative to the transcription start site of the human α4integrin gene was transiently co-transfected into HEK293 cells along with expression constructs encoding for two different Wt1 protein forms. These two Wt1 variants differ by the presence/absence of three amino acids (lysine-threonine-serine, KTS) in the zinc finger domain of the molecule. Compared with cotransfection of the empty pCB6 + vector, reporter activity was stimulated over 3-fold by the Wt1(-KTS) expression construct, which lacks the tripeptide insertion ( Fig. 2A) . In contrast, the Wt1(+KTS) molecule, which has a role in mRNA processing rather than transcriptional regulation (15-18), did not activate the promoter of the α4integrin gene ( Fig. 2A) . To delineate the cis-element(s) necessary for activation of the α4integrin promoter by Wt1(-KTS), we generated different constructs with variable truncations and/or deletions of the original sequence ( Fig. 2A) . Remarkably, a promoter sequence from -283 to +1 bp relative to the transcription initiation site was stimulated more than 10-fold by the Wt1(-KTS) protein, but not by the Wt1(+KTS) variant (Fig. 2A) . Luciferase activity under control of an α4integrin promoter fragment, which extended from -1864 to -263 bp, was not changed significantly by cotransfection of Wt1(-KTS) (Fig. 2A) . These results suggest that the regulatory binding motif(s) for Wt1 are located between -283 and +1 bp relative to the transcription start site in the α4integrin gene. For further analysis, the GCrich proximal α4integrin promoter region was subdivided into two shorter fragments between -283 and -171 bp, and between -104 and +1 bp, respectively. Remarkably, co-transfection of Wt1(-KTS) with either one of these constructs increased the reporter activity more than 10-fold ( Fig. 2A) indicating that at least two separate elements in the α4integrin promoter can mediate the stimulatory effect of Wt1(-KTS).
A survey of the Wt1(-KTS)-responsive α4integrin promoter sequence revealed two predicted Wt1 consensus elements that were located between -263 and -238 bp (oligo A) and between -70 and -47 bp (oligo B) relative to the transcription start site (Fig. 2B) . Electrophoretic mobility shift assays were performed to investigate whether these two oligonucleotides can interact with the Wt1 molecules. Specific retardation bands reflecting binding of recombinant Wt1(-KTS) protein were obtained with oligos A and B (Fig. 3) . For comparison, the Wt1(+KTS) molecule had a lower affinity for oligo B and did not interact with oligo A (Fig.  3) . Binding of the Wt1(-KTS) protein to oligos A and B could be competed with an unlabeled DNA, which contained the previously identified Wt1(-KTS) consensus site of the vitamin D receptor gene promoter (42) . Introducing point mutations into each one of the two oligonucleotides abolished binding of the Wt1(-KTS) protein (Fig. 3) . Consistent with these findings, activation of the α4integrin promoter by the Wt1(-KTS) form was abrogated with a ≈1.9 kb reporter construct, which harbored both mutations (mutation A and mutation B) in combination (Fig. 4A) .
Introducing either mutation A or mutation B alone did not abolish activation of the α4integrin promoter by Wt1(-KTS) (data not shown). These findings indicate that two cis-regulatory elements mediate the activation of the α4integrin promoter by the Wt1(-KTS) protein.
Binding of Wt1 to the α4integrin promoter was confirmed by ChIP assay in K562 leukemia cells (Fig. 4B) , which are widely used to study Wt1 regulation (52, 53) and also express the α4integrin gene (49) . The specificity of Wt1 interaction with the α4integrin promoter is indicated by the lack of a PCR product when the same samples were amplified with primers for the 3'-region of the gene (Fig. 4B) .
Next we explored whether enhanced α4integrin expression would increase the adhesion of Wt1-tranfected HEK293 cells to VCAM-1, one natural ligand of α4integrin (35, 36) . For this purpose, HEK293 cells with stable expression of the Wt1(-KTS) protein were seeded on tissue culture plates that had been coated with VCAM-1. HEK293 cells with stable integration of the empty pCB6 + vector were used as a negative control. Remarkably, 87±6% of the Wt1(-KTS)-transfected cells became adherent within 30 min after seeding on the VCAM-1-coated plates (Fig. 5) .
For comparison, only 12±7% of the pCB6 + -transfected HEK293 cells were attached after 30 min (Fig. 5) . To test whether cell adhesion was mediated by interaction of α4integrin with VCAM-1, the cells were incubated with an inhibitory α4integrin antibody for 1h before seeding (44) . Preincubation with this antibody reduced the fraction of adherent Wt1-transfected HEK293 cells from 87±6% to 12±7% (Fig. 5) . Less than 3% of all cells, no matter whether they had been transfected with the pCB6 + plasmid or with the Wt1(-KTS) expression construct, became adherent to uncoated (without VCAM-1) tissue culture plates within the 30 min period (Fig. 5) . Cell viability, which was tested with the use of the Celltracer reagent (Invitrogen, Molecular Probes), was above 95% in suspensions of both pCB6 + -and Wt1(-KTS)-transfected cells. Consequently, almost 100% of the pCB6 + -transfected HEK293 cells became attached to the bottom of the tissue culture plates within 4h after seeding indicating that their general capacity to grow adherent was maintained. These findings show that forced expression of Wt1 stimulates adhesion of HEK293 cells through the binding of α4integrin to its receptor VCAM-1.
Finally we explored whether Wilms' tumor proteins can possibly regulate α4integrin gene expression also in vivo.
A double immunofluorescent technique for labeling of the Wt1 (red fluorescence, Cy3) and α4integrin expressing cells (green fluorescence, Cy2) was applied to analyze the distribution of both molecules in the developing heart of murine embryos. As reported earlier (8,54,55), Wt1 was present in the epicardium of mouse embryos at 11.5 d.p.c. (Fig. 6) . High power magnification and counterstaining with Dapi revealed that Wt1 expression in epicardial cells was nuclear, whereas α4integrin could be detected in the plasma membrane (Fig. 6) .
In contrast, myocardial cells did not stain for Wt1 or α4integrin (Fig. 6) .
To examine whether Wt1 is necessary for normal expression of α4integrin in vivo, we measured transcript levels by real-time RT-PCR in the hearts of wild-type and Wt1-deficient mouse embryos (Wt1 -/-) at 12.5 d.p.c.. Hearts were chosen, because α4integrin and Wt1 are co-localized in the epicardial cells (Fig. 6) , and we could show recently that Wt1 is required for normal cardiac development (38) . Compared to wild-type mice, α4integrin transcripts were reduced by 57% in the hearts of Wt1 -/-embryos (Fig. 7A) . In contrast, no significant differences in α4integrin mRNA were seen between the livers of normal and Wt1 -/-embryos (Fig. 7B) . Unlike the α4integrin mRNA, the transcripts for ß1integrin and VCAM-1 were not significantly different between the hearts of normal and Wt1 -/-mice (Fig. 7C,D) indicating that gene expression was not generally down-regulated in Wt1-deficient tissues. Similarly, endo B cytokeratin (K18), which is expressed in the epicardium but not in cardiac myocytes (56) , was insignificantly reduced in Wt1-deficient vs. wild-type embryos (Fig. 7E) .
Murine embryos with inactivated Wt1 gene have previously been reported to lack part of their epicardium (8). To explore whether Wt1 would be necessary for the expression of α4integrin in the remaining epicardial cells in Wt1-deficient embryos, we applied an immunoperoxidase-based staining technique. Figure 8 shows that α4integrin could be readily detected in the epicardium of wild-tpye embryos, but was barely seen in Wt1 -/-littermates at E11.5. For comparison, immunoreactivity of vimentin, which is expressed in mesenchymal cells including the immature epicardium (57) , was maintained in Wt1 -/-embryos (Fig. 8) . These results suggest that Wt1 is a critical factor for the normal expression of α4integrin in the developing mouse heart.
DISCUSSION
We have recently demonstrated that the Wilms' tumor suppressor Wt1, in extension to its previously recognized functions during organ development, is also required for blood vessel formation in the embryonic heart (38) . In the same study, Ntrk2, the gene encoding the TrkB neurotrophin receptor, was identified as a first candidate target for the vasculogenic action of Wt1 in the myocardium (38) . Enhanced transcription of Ntrk2 by Wt1 may prevent the newly formed blood vessels in the developing heart from becoming apoptotic (58) . Whilst these findings for the first time established a role for Wt1 during later stages of blood vessel formation in the heart, little is known about the molecular signaling pathways of Wt1 during early steps of cardiac development. Our present findings provide circumstantial evidence that transcriptional activation of the α4integrin gene, which encodes a transmembrane cell adhesion molecule, could be a regulatory mechanism for the formation of the epicardium.
Notably, the epicardium is of critical importance for the configuration of the intramyocardial vasculature as it supplies the progenitors for vascular smooth muscle and endothelial cells as well as perivascular fibroblasts (59, 60) . Unraveling the transcriptional program in epicardial cells may therefore permit significant novel insights into the early steps of blood vessel formation in the heart.
The epicardium is a single-layered mesothelial tissue on the outer surface of the myocardium, which originates from an extracardiac primordium, the so-called proepicardial serosa (reviewed in 61,62). Remarkably, embryos with inactivation of the α4integrin gene (α4integrin -/-), like Wt1-null mutants (3,8,38) , exhibit a failure of normal formation of the epicardium and the coronary vasculature (37) . An essential step in the development of the epicardium is the attachment of the progenitor cells to the outer surface of the heart. The cardiac phenotype of the α4integrin knockout embryos suggests that α4integrin is necessary for both, the initial migration of the epicardial progenitor cells and their contact formation with the myocardium (37, 62) . In support of this, similar epicardial defects were observed in mice lacking VCAM-1 (63), a natural ligand of α4integrin (35, 36) . Extending previous reports by other groups (8,64,65), our observations demonstrate that α4integrin and Wt1 are co-expressed in the developing epicardium. Unfortunately, epicardial cell lines are not available to study the relationship between Wt1 and α4integrin in a more physiological cellular context. However, since Wt1(-KTS) promotes the adhesion of cultured embryonic kidney cells by upregulating the α4integrin gene, it is intriguing that Wt1 may facilitate the attachment of proepicardial cells to the surface of the heart through a similar mechanism. Remarkably, α4integrin mRNA was reduced significantly in the hearts of Wt1-deficient vs. wild-type embryos. Furthermore, α4integrin immunoreactivity was lost in the remaining epicardial cells of the Wt1 -/-mutants. While a partial defect of the epicardium (8) may contribute to the lower α4integrin content in the Wt1 -/-hearts, our findings suggest that Wt1 is indeed necessary for normal expression of α4integrin in the developing epicardial cells.
The two cis-elements in the α4integrin promoter that mediate the transactivation by Wt1(-KTS) are highly homologous with previously recognized binding motifs in other Wt1 target genes (38, 45, 66, 67) . Each one of the identified regulatory elements alone was sufficient to confer the full Wt1(-KTS)-responsiveness to a heterologous α4integrin promoter-reporter construct. Accordingly, the stimulatory effect of Wt1(-KTS) on the α4integrin promoter was not significantly attenuated unless both bindings sequences (oligo A and oligo B) were mutated. These observations suggest that Wt1(-KTS) activates the α4integrin promoter with some functional redundancy, thus underlining its importance for α4integrin regulation. In general, the shorter proximal promoter pieces were more susceptible to stimulation by Wt1(-KTS) than the larger ≈1.9 kb construct.
We therefore assume that additional, inhibitory elements are present in the α4integrin promoter, which are located 5' to the Wt1-responsive sites and counteract the effect of Wt1(-KTS). This structural organization permits a balanced regulation of promoter activity through the recruitment of trans-acting factors to their available cis-regulatory binding sites. Notably, the proximal Wt1(-KTS)-responsive sequence (oligo B) overlapped with three nearby consensus elements (GGAA/T) for Ets transcription factors. In addition to the Pax-6 gene product, which acts through another cisregulatory site (68) , Ets proteins have previously been reported to stimulate the α4integrin promoter through binding to these elements (46) . Like Pax-6 and Wt1, the Ets transcription factors are expressed in a developmental pattern and were detected in lymphatic and hematopoietic tissues in addition to vascular endothelial and smooth muscle cells (reviewed in 69). In the light of our recent findings demonstrating Wt1 in vascular endothelial and smooth muscle cells of the coronary system (38, 70) , it is conceivable that Wt1(-KTS) and Ets factors may act synergistically to stimulate α4integrin expression. Moreover, transcriptional control of the α4integrin promoter seems to fulfill a major purpose by restricting gene expression in a tissue-and developmental-specific mode.
In summary, we identified an alternative splice variant of the Wilms' tumor suppressor Wt1 as a novel transcriptional activator of the α4integrin gene. It is suggested that stimulation of α4integrin expression by Wt1 may promote cell adhesion in the epicardium and possibly also in other tissues during embryonic development. Considering the proposed role of cell adhesion receptors in tumor invasion and metastasis (reviewed in 31), one can speculate whether down-regulation of α4integrin in nephroblastoma would favor progression of the disease.
More elaborate studies will be necessary to further explore the link between Wt1 and α4integrin and its potential role in tumorigenesis. PCR-amplified products of the immunoprecipitates were electrophoresed in a 1.5% agarose gel and stained with ethidium bromide; for better visualization the gel photograph is presented as negative of the original. Apparently, Wt1 binds to the 5'-promoter, but not to the 3'-region of the α4integrin gene. Input DNA (1:10 dilution) and immunoprecipitates obtained with acetylated histone 3 antibody (Acetyl. H3) served as positive controls. Additional negative control experiments were performed with normal rabbit serum instead of specific antibodies. 
